Abstract
P-286 Impact of hypogammaglobulinemia and immunoglobulin replacement therapy on infection rate in patients with RRMM treated with elranatamab: post-hoc analysis from MagnetisMM-3
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have